HDAC4 and Parkinson disease: Here, we attempted to selectively inhibit HDAC4 in the rotenone-induced SH-SY5Y cell model of PD, and explore its effects on α-syn levels, autophagy activity, and cell viability and, therefore, to seek scientific evidence for a new targeted therapy for PD.